Ethambutol Production Cost Reports

The report provides a detailed analysis essential for establishing an Ethambutol production plant. It encompasses all critical aspects necessary for Ethambutol production, including the cost of Ethambutol production, Ethambutol plant cost, Ethambutol production costs, and the overall Ethambutol production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating an Ethambutol production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Ethambutol is an important pharmaceutical compound primarily used in the treatment of tuberculosis. It is primarily prescribed as part of combination therapy along with other anti-tuberculosis medicines to improve treatment effectiveness. It works by inhibiting mycobacterial cell wall synthesis, which helps control the infection and reduces the risk of drug resistance. It is commonly used in the management of pulmonary tuberculosis and is also effective in treating tuberculosis that affects other parts of the body. It also finds its application in the treatment of infections caused by non-tuberculous mycobacteria. It is available in oral dosage forms and is included in national and global tuberculosis control programs. In clinical settings, its role is vital in the initial phase of TB treatment, especially when drug resistance is suspected or confirmed.

The market for Ethambutol is predominantly led by its application as a drug in long-term tuberculosis treatment programs to support successful disease control, which promotes its demand in the pharmaceutical industry. Its application as a part of a multi-drug regimen to prevent the development of drug resistance in Mycobacterium tuberculosis also contributes to its demand in the medical and pharmaceutical industries. Its role as a first-line antitubercular agent used in the treatment of active tuberculosis also strengthens its demand in the healthcare sector. Moreover, its usage in the treatment of certain infections caused by non-tuberculous mycobacteria further boosts its demand in the medical sector.

Industrial Ethambutol procurement depends on factors such as the availability and cost of raw materials (e.g., aminobutanol derivatives), regulatory standards for active pharmaceutical ingredients, and compliance with global quality certifications. In addition, supplier reliability, production efficiency, and streamlined logistics play a crucial role in maintaining stable supply chains, while environmental and sustainability guidelines also impact procurement strategies.

Raw Material for Ethambutol Production

According to the Ethambutol production plant project report, the major raw materials for Ethambutol production include Nitropropane, Formaldehyde, L-tartaric acid, and 1,2-dichloroethane; Ethyl Ester of L-2-aminobutyric acid hydrochloride and 1,2-dichloroethane.

Production Processes of Ethambutol

The extensive Ethambutol production cost report consists of the following industrial production processes:

• Production via Oxymethylation: The production process of Ethambutol begins with the oxymethylation of nitropropane using formaldehyde to form 2-nitrobutanol. The nitro group in this intermediate is then reduced by hydrogen to form racemic (±) 2-aminobutanol. Further, L-tartaric acid is used to separate the desired (L)-2-aminobutanol. Then, the obtained (L)-2-aminobutanol is reacted with 1,2-dichloroethane in the presence of sodium hydroxide to obtain Ethambutol as the final product.
   
• Production via Reduction: The production process of Ethambutol begins with the reduction of the ethyl ester of L-2-aminobutyric acid hydrochloride using hydrogen in the presence of both Raney nickel and platinum oxide catalysts. The process of reduction gives pure (L)-2-aminobutanol. Then, the resulting (L)-2-aminobutanol is reacted with 1,2-dichloroethane in the presence of sodium hydroxide, which leads to the formation of Ethambutol as the final product.

Ethambutol is a bacteriostatic antimycobacterial agent used primarily in the treatment of tuberculosis. It appears as a viscous light yellow oil, although it can form white crystals upon recrystallisation. The free base has a melting point of approximately 88 degree Celsius, while the recrystallised form melts at 128 to 132.5 degree Celsius. The molecular formula of the compound is C10H24N2O2, and its molecular weight is 204.31 g/mol. The compound is water-soluble and heat-stable, and it is commonly formulated and administered as the dihydrochloride salt, which is freely soluble in water and alcohol. The compound is marketed under various brand names, including Myambutol, Etibi, and Diambutol. The most serious side effect is dose-related and duration-dependent optic neuropathy, which causes decreased visual acuity, red-green colour blindness, and central scotomas. Prolonged exposure may cause serious health problems, including irreversible vision loss, peripheral neuritis, liver damage, elevated serum uric acid levels, acute gout, gastrointestinal disturbances, and neurological abnormalities. It is advised to regularly monitor visual acuity and colour discrimination during treatment, and the medication should not be used in patients with optic neuritis.